Key Market Indicators
Sales of German antirheumatic medicines are projected to fall slightly in the coming years, dropping 0.5% annually on average. This follows a downward trend that has been in place since 1991, when the country registered a 0.6% year-on-year decrease. In 2021, Germany’s antirheumatic medicine sales amounted to $605 million, making it the second-largest market worldwide. South Korea led the way with $634 million, followed by Spain ($564 million) and Canada ($507 million).
